Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
VNET Group, Inc.
13G
VNET · 90138A103
|
5.0% |
1/9/2026
Event 1/8/2026
|
|||
| Point72 Asset Management, L.P. | 4.8% | ||||
| Point72 Capital Advisors, Inc. | 4.8% | ||||
| Point72 Europe (London) LLP | 0.2% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Ovid Therapeutics Inc.
13G
OVID · 690469101
|
5.1% |
1/5/2026
Event 1/2/2026
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Century Therapeutics, Inc.
13G
IPSC · 15673T100
|
5.4% |
1/5/2026
Event 12/23/2025
|
|||
| Point72 Asset Management, L.P. | 5.4% | ||||
| Point72 Capital Advisors, Inc. | 5.4% | ||||
| Steven A. Cohen | 5.4% | ||||
|
Tonix Pharmaceuticals Holding Corp.
13G
TNXP · 890260839
|
9.2% |
12/31/2025
Event 12/29/2025
|
|||
| Point72 Asset Management, L.P. | 9.2% | ||||
| Point72 Capital Advisors, Inc. | 9.2% | ||||
| Steven A. Cohen | 9.2% | ||||
|
BILL Holdings, Inc.
13G
BILL · 090043100
|
5.0% |
11/24/2025
Event 11/21/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Cogent Biosciences, Inc.
13G/A
Amendment 4
COGT · 19240Q201
|
4.0% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 4.0% | ||||
| Point72 Capital Advisors, Inc. | 4.0% | ||||
| Steven A. Cohen | 4.0% | ||||
|
Cybin Inc.
13G/A
Amendment 2
HELP · 23256X407
|
9.9% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
Confluent, Inc.
13G/A
Amendment 1
CFLT · 20717M103
|
6.0% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 6.0% | ||||
| Point72 Capital Advisors, Inc. | 6.0% | ||||
| Steven A. Cohen | 6.0% | ||||
|
Turnstone Biologics Corp.
13G/A
Amendment 1
TSBX · 90042W100
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Point72 Biotech Private Investments, LLC | 0% | ||||
| Differentiated Ventures Investments, LLC | 0% | ||||
| 72 Investment Holdings, LLC | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
PepGen Inc.
13G/A
Amendment 2
PEPG · 713317105
|
3.0% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 3.0% | ||||
| Point72 Capital Advisors, Inc. | 3.0% | ||||
| Steven A. Cohen | 3.0% | ||||
|
Mobileye Global Inc.
13G/A
Amendment 2
MBLY · 60741F104
|
2.8% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.8% | ||||
| Point72 Capital Advisors, Inc. | 2.8% | ||||
| Point72 Italy, S.r.l. | 0% | ||||
| Steven A. Cohen | 2.8% | ||||
|
Cidara Therapeutics, Inc.
13G/A
Amendment 2
CDTX · 171757206
|
6.2% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Replimune Group, Inc.
13G/A
Amendment 1
REPL · 76029N106
|
4.7% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 4.7% | ||||
| Point72 Capital Advisors, Inc. | 4.7% | ||||
| Steven A. Cohen | 4.7% | ||||
|
FG Nexus Inc.
13G/A
Amendment 1
FGNX · 30329Y304
|
9.9% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
Avalo Therapeutics, Inc.
13G/A
Amendment 1
AVTX · 05338F306
|
8.0% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 8.0% | ||||
| Point72 Capital Advisors, Inc. | 8.0% | ||||
| Steven A. Cohen | 8.0% | ||||
|
Amylyx Pharmaceuticals, Inc.
13G/A
Amendment 1
AMLX · 03237H101
|
2.6% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.6% | ||||
| Point72 Capital Advisors, Inc. | 2.6% | ||||
| Steven A. Cohen | 2.6% | ||||
|
Angiodynamics Inc
13G/A
Amendment 1
ANGO · 03475V101
|
6.2% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Zepp Health Corp
13G/A
Amendment 1
ZEPP · 98945L204
|
7.6% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 7.6% | ||||
| Point72 Capital Advisors, Inc. | 7.6% | ||||
| Steven A. Cohen | 7.6% | ||||
|
Teladoc Health, Inc.
13G/A
Amendment 1
TDOC · 87918A105
|
3.3% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 3.3% | ||||
| Point72 Capital Advisors, Inc. | 3.3% | ||||
| Steven A. Cohen | 3.3% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 2
CTMX · 23284F105
|
2.5% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.5% | ||||
| Point72 Capital Advisors, Inc. | 2.5% | ||||
| Steven A. Cohen | 2.5% | ||||
|
Arcus Biosciences, Inc.
13G/A
Amendment 1
RCUS · 03969F109
|
4.1% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 4.1% | ||||
| Point72 Capital Advisors, Inc. | 4.1% | ||||
| Steven A. Cohen | 4.1% | ||||
|
Ventyx Biosciences, Inc.
13G/A
Amendment 2
VTYX · 92332V107
|
4.5% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 4.5% | ||||
| Point72 Capital Advisors, Inc. | 4.5% | ||||
| Steven A. Cohen | 4.5% | ||||
|
Entera Bio Ltd.
13G/A
Amendment 1
ENTX · M40527109
|
2.6% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.6% | ||||
| Point72 Capital Advisors, Inc. | 2.6% | ||||
| Steven A. Cohen | 2.6% | ||||
|
Tower Semiconductor Ltd
13G/A
Amendment 3
TSEM · M87915274
|
2.6% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.6% | ||||
| Point72 Capital Advisors, Inc. | 2.6% | ||||
| Steven A. Cohen | 2.6% | ||||
|
PagSeguro Digital Ltd.
13G/A
Amendment 5
PAGS · G68707101
|
5.7% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Sphere Entertainment Co.
13G/A
Amendment 4
SPHR · 55826T102
|
0.8% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 0.8% | ||||
| Point72 Capital Advisors, Inc. | 0.8% | ||||
| Steven A. Cohen | 0.8% | ||||
|
LENZ Therapeutics, Inc.
13G/A
Amendment 1
LENZ · 52635N103
|
4.8% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 1.2% | ||||
| Point72 Capital Advisors, Inc. | 1.2% | ||||
| Point72 Biotech Private Investments, LLC | 3.6% | ||||
| Differentiated Ventures Investments, LLC | 3.6% | ||||
| 72 Investment Holdings, LLC | 3.6% | ||||
| Steven A. Cohen | 4.8% | ||||
|
Xilio Therapeutics, Inc.
13G/A
Amendment 1
XLO · 98422T100
|
9.9% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
Wolverine World Wide Inc /DE/
13G/A
Amendment 1
WWW · 978097103
|
6.2% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Invivyd, Inc.
13G/A
Amendment 1
IVVD · 00534A102
|
9.7% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 9.7% | ||||
| Point72 Capital Advisors, Inc. | 9.7% | ||||
| Steven A. Cohen | 9.7% | ||||
|
KALA BIO, Inc.
13G/A
Amendment 1
KALA · 483119202
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 6
PRAX · 74006W207
|
9.6% |
11/14/2025
Event 9/30/2025
|
|||
| Point72 Asset Management, L.P. | 9.3% | ||||
| Point72 Capital Advisors, Inc. | 9.3% | ||||
| Point72 Biotech Private Investments, LLC | 0.3% | ||||
| Differentiated Ventures Investments, LLC | 0.3% | ||||
| 72 Investment Holdings, LLC | 0.3% | ||||
| Steven A. Cohen | 9.6% | ||||
|
Black Rock Coffee Bar, Inc.
13G
BRCB · 092244102
|
5.4% |
11/13/2025
Event 11/12/2025
|
|||
| Point72 Asset Management, L.P. | 5.4% | ||||
| Point72 Capital Advisors, Inc. | 5.4% | ||||
| Point72 Europe (London) LLP | 0% | ||||
| Steven A. Cohen | 5.4% | ||||
|
Galecto, Inc.
13G
DMRA · 36322Q206
|
6.3% |
11/13/2025
Event 11/12/2025
|
|||
| Point72 Asset Management, L.P. | 6.3% | ||||
| Point72 Capital Advisors, Inc. | 6.3% | ||||
| Steven A. Cohen | 6.3% | ||||
|
Palatin Technologies Inc
13G
PTN · 696077601
|
9.9% |
11/13/2025
Event 11/12/2025
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
Lionsgate Studios Corp.
13G
LION · 53626N102
|
5.1% |
11/3/2025
Event 10/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Tenax Therapeutics, Inc.
13G
TENX · 88032L605
|
7.4% |
10/29/2025
Event 10/22/2025
|
|||
| Point72 Asset Management, L.P. | 7.4% | ||||
| Point72 Capital Advisors, Inc. | 7.4% | ||||
| Steven A. Cohen | 7.4% | ||||
|
C4 Therapeutics, Inc.
13G
CCCC · 12529R107
|
9.9% |
10/20/2025
Event 10/17/2025
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
Wolfspeed, Inc.
13G
WOLF · 97785W106
|
6.0% |
10/10/2025
Event 10/9/2025
|
|||
| Point72 Asset Management, L.P. | 5.6% | ||||
| Point72 Capital Advisors, Inc. | 5.6% | ||||
| Point72 Europe (London) LLP | 0.4% | ||||
| Steven A. Cohen | 6.0% | ||||
|
Palisade Bio, Inc.
13G
PALI · 696389402
|
6.2% |
10/7/2025
Event 10/6/2025
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Aptevo Therapeutics Inc.
13G
APVO · 03835L504
|
9.1% |
9/17/2025
Event 9/16/2025
|
|||
| Point72 Asset Management, L.P. | 9.1% | ||||
| Point72 Capital Advisors, Inc. | 9.1% | ||||
| Steven A. Cohen | 9.1% | ||||
|
Dianthus Therapeutics, Inc. /DE/
13G
DNTH · 252828108
|
5.3% |
9/12/2025
Event 9/11/2025
|
|||
| Point72 Asset Management, L.P. | 5.3% | ||||
| Point72 Capital Advisors, Inc. | 5.3% | ||||
| Steven A. Cohen | 5.3% | ||||
|
KALA BIO, Inc.
13G
KALA · 483119202
|
6.7% |
9/11/2025
Event 9/4/2025
|
|||
| Point72 Asset Management, L.P. | 6.7% | ||||
| Point72 Capital Advisors, Inc. | 6.7% | ||||
| Steven A. Cohen | 6.7% | ||||
|
FG Nexus Inc.
13G
FGNX · 30329Y304
|
9.8% |
9/11/2025
Event 9/5/2025
|
|||
| Point72 Asset Management, L.P. | 9.8% | ||||
| Point72 Capital Advisors, Inc. | 9.8% | ||||
| Steven A. Cohen | 9.8% | ||||
|
Pliant Therapeutics, Inc.
13G
PLRX · 729139105
|
6.7% |
9/4/2025
Event 8/27/2025
|
|||
| Point72 Asset Management, L.P. | 6.7% | ||||
| Point72 Capital Advisors, Inc. | 6.7% | ||||
| Steven A. Cohen | 6.7% | ||||
|
Wolverine World Wide Inc /DE/
13G
WWW · 978097103
|
5.0% |
8/29/2025
Event 8/28/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Cohen A. Steven | 5.0% | ||||
|
Design Therapeutics, Inc.
13G
DSGN · 25056L103
|
5.2% |
8/28/2025
Event 8/27/2025
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Invivyd, Inc.
13G
IVVD · 00534A102
|
8.0% |
8/27/2025
Event 8/26/2025
|
|||
| Point72 Asset Management, L.P. | 8.0% | ||||
| Point72 Capital Advisors, Inc. | 8.0% | ||||
| Steven A. Cohen | 8.0% | ||||
|
iBio, Inc.
13G
IBIO · 451033708
|
9.9% |
8/25/2025
Event 8/22/2025
|
|||
| Point72 Asset Management, L.P. | 9.9% | ||||
| Point72 Capital Advisors, Inc. | 9.9% | ||||
| Steven A. Cohen | 9.9% | ||||
|
Kodiak Sciences Inc.
13G
KOD · 50015M109
|
5.5% |
8/19/2025
Event 8/15/2025
|
|||
| Point72 Asset Management, L.P. | 5.5% | ||||
| Point72 Capital Advisors, Inc. | 5.5% | ||||
| Steven A. Cohen | 5.5% | ||||
|
Syndax Pharmaceuticals Inc
13G
SNDX · 87164F105
|
5.0% |
8/18/2025
Event 8/15/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
ALT5 Sigma Corp
13G
ALTS · 74347B813
|
4.0% |
8/18/2025
Event 8/11/2025
|
|||
| Point72 Asset Management, L.P. | 4.0% | ||||
| Point72 Capital Advisors, Inc. | 4.0% | ||||
| Steven A. Cohen | 4.0% | ||||
|
Syndax Pharmaceuticals Inc
13G/A
Amendment 1
SNDX · 87164F105
|
2.7% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.7% | ||||
| Point72 Capital Advisors, Inc. | 2.7% | ||||
| Steven A. Cohen | 2.7% | ||||
|
VNET Group, Inc.
13G/A
Amendment 1
VNET · 90138A103
|
2.4% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 2.1% | ||||
| Point72 Capital Advisors, Inc. | 2.1% | ||||
| Point72 Europe (London) LLP | 0.3% | ||||
| Steven A. Cohen | 2.4% | ||||
|
Dianthus Therapeutics, Inc. /DE/
13G/A
Amendment 1
DNTH · 252828108
|
4.5% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 4.5% | ||||
| Point72 Capital Advisors, Inc | 4.5% | ||||
| Steven A. Cohen | 4.5% | ||||
|
Shoals Technologies Group, Inc.
13G/A
Amendment 1
SHLS · 82489W107
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 1
CTMX · 23284F105
|
5.1% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Cidara Therapeutics, Inc.
13G/A
Amendment 1
CDTX · 171757206
|
7.6% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 7.6% | ||||
| Point72 Capital Advisors, Inc. | 7.6% | ||||
| Steven A. Cohen | 7.6% | ||||
|
Lumentum Holdings Inc.
13G/A
Amendment 3
LITE · 55024U109
|
1.3% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 1.3% | ||||
| Point72 Capital Advisors, Inc. | 1.3% | ||||
| Point72 Italy S.R.L. | 0% | ||||
| Steven A. Cohen | 1.3% | ||||
|
Cybin Inc.
13G/A
Amendment 1
HELP · 23256X407
|
7.0% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 7.0% | ||||
| Point72 Capital Advisors, Inc. | 7.0% | ||||
| Steven A. Cohen | 7.0% | ||||
|
Regulus Therapeutics Inc.
13G/A
Amendment 1
RGLS · 75915K309
|
0.3% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 0.3% | ||||
| Point72 Capital Advisors, Inc. | 0.3% | ||||
| Steven A. Cohen | 0.3% | ||||
|
Sagimet Biosciences Inc.
13G/A
Amendment 3
SGMT · 786700104
|
0% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 5
PRAX · 74006W207
|
7.3% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 7.0% | ||||
| Point72 Capital Advisors, Inc. | 7.0% | ||||
| Point72 Biotech Private Investments, LLC | 0.3% | ||||
| Differentiated Ventures Investments, LLC | 0.3% | ||||
| 72 Investment Holdings, LLC | 0.3% | ||||
| Steven A. Cohen | 7.3% | ||||
|
Ventyx Biosciences, Inc.
13G/A
Amendment 1
VTYX · 92332V107
|
8.3% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 8.3% | ||||
| Point72 Capital Advisors, Inc. | 8.3% | ||||
| Steven A. Cohen | 8.3% | ||||
|
Relay Therapeutics, Inc.
13G/A
Amendment 1
RLAY · 75943R102
|
7.8% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 7.8% | ||||
| Point72 Capital Advisors, Inc. | 7.8% | ||||
| Steven A. Cohen | 7.8% | ||||
|
Korro Bio, Inc.
13G/A
Amendment 2
KRRO · 500946108
|
8.7% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 5.8% | ||||
| Point72 Capital Advisors, Inc. | 5.8% | ||||
| Point72 Biotech Private Investments, LLC | 2.9% | ||||
| Differentiated Ventures Investments, LLC | 2.9% | ||||
| 72 Investment Holdings, LLC | 2.9% | ||||
| Steven A. Cohen | 8.7% | ||||
|
PagSeguro Digital Ltd.
13G/A
Amendment 4
PAGS · G68707101
|
6.7% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 6.7% | ||||
| Point72 Capital Advisors, Inc. | 6.7% | ||||
| Steven A. Cohen | 6.7% | ||||
|
Bicycle Therapeutics PLC
13G/A
Amendment 2
BCYC · 088786108
|
3.9% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 3.9% | ||||
| Point72 Capital Advisors, Inc. | 3.9% | ||||
| Steven A. Cohen | 3.9% | ||||
|
Tower Semiconductor Ltd
13G/A
Amendment 2
TSEM · M87915274
|
5.7% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
StoneCo Ltd.
13G/A
Amendment 1
STNE · G85158106
|
3.9% |
8/14/2025
Event 6/30/2025
|
|||
| Point72 Asset Management, L.P. | 3.9% | ||||
| Point72 Capital Advisors, Inc. | 3.9% | ||||
| Steven A. Cohen | 3.9% | ||||
|
Avalo Therapeutics, Inc.
13G
AVTX · 05338F306
|
5.4% |
8/5/2025
Event 8/4/2025
|
|||
| Point72 Asset Management, L.P. | 5.4% | ||||
| Point72 Capital Advisors, Inc. | 5.4% | ||||
| Steven A. Cohen | 5.4% | ||||
|
Replimune Group, Inc.
13G
REPL · 76029N106
|
5.7% |
7/31/2025
Event 7/30/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Verastem, Inc.
13G
VSTM · 92337C203
|
6.1% |
7/28/2025
Event 7/25/2025
|
|||
| Point72 Asset Management, L.P. | 6.1% | ||||
| Point72 Capital Advisors, Inc. | 6.1% | ||||
| Steven A. Cohen | 6.1% | ||||
|
Zepp Health Corp
13G
ZEPP · 98945L204
|
5.7% |
7/18/2025
Event 7/17/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Angiodynamics Inc
13G
ANGO · 03475V101
|
5.2% |
7/17/2025
Event 7/16/2025
|
|||
| Point72 Asset Management, L.P. | 5.2% | ||||
| Point72 Capital Advisors, Inc. | 5.2% | ||||
| Steven A. Cohen | 5.2% | ||||
|
Celldex Therapeutics, Inc.
13G
CLDX · 15117B202
|
6.7% |
7/10/2025
Event 7/2/2025
|
|||
| Point72 Asset Management, L.P. | 6.7% | ||||
| Point72 Capital Advisors, Inc. | 6.7% | ||||
| Steven A. Cohen | 6.7% | ||||
|
1RT Acquisition Corp.
13G
ONCHU · G6757R121
|
8.7% |
7/7/2025
Event 7/3/2025
|
|||
| Point72 Asset Management, L.P. | 8.7% | ||||
| Point72 Capital Advisors, Inc. | 8.7% | ||||
| Steven A. Cohen | 8.7% | ||||
|
Sunrun Inc.
13G
RUN · 86771W105
|
5.0% |
6/27/2025
Event 6/26/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Amylyx Pharmaceuticals, Inc.
13G
AMLX · 03237H101
|
5.3% |
6/25/2025
Event 6/24/2025
|
|||
| Point72 Asset Management, L.P. | 5.3% | ||||
| Point72 Capital Advisors, Inc. | 5.3% | ||||
| Steven A. Cohen | 5.3% | ||||
|
Confluent, Inc.
13G
CFLT · 20717M103
|
5.1% |
6/24/2025
Event 6/23/2025
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
ADC Therapeutics SA
13G
ADCT · H0036K147
|
7.0% |
6/17/2025
Event 6/16/2025
|
|||
| Point72 Asset Management, L.P. | 7.0% | ||||
| Point72 Capital Advisors, Inc. | 7.0% | ||||
| Steven A. Cohen | 7.0% | ||||
|
Xilio Therapeutics, Inc.
13G
XLO · 98422T100
|
7.2% |
6/17/2025
Event 6/5/2025
|
|||
| Point72 Asset Management, L.P. | 7.2% | ||||
| Point72 Capital Advisors, Inc. | 7.2% | ||||
| Steven A. Cohen | 7.2% | ||||
|
IDEAYA Biosciences, Inc.
13G
IDYA · 45166A102
|
5.0% |
6/9/2025
Event 6/6/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Oric Pharmaceuticals, Inc.
13G
ORIC · 68622P109
|
5.1% |
6/4/2025
Event 5/29/2025
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Cybin Inc.
13G
HELP · 23256X407
|
6.3% |
5/21/2025
Event 5/20/2025
|
|||
| Point72 Asset Management, L.P. | 6.3% | ||||
| Point72 Capital Advisors, Inc. | 6.3% | ||||
| Steven A. Cohen | 6.3% | ||||
|
Teladoc Health, Inc.
13G
TDOC · 87918A105
|
5.0% |
5/19/2025
Event 5/16/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 4
PRAX · 74006W207
|
5.8% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.5% | ||||
| Point72 Capital Advisors, Inc. | 5.5% | ||||
| Point72 Biotech Private Investments, LLC | 0.3% | ||||
| Differentiated Ventures Investments, LLC | 0.3% | ||||
| 72 Investment Holdings, LLC | 0.3% | ||||
| Steven A. Cohen | 5.8% | ||||
|
Bicycle Therapeutics PLC
13G/A
Amendment 1
BCYC · 088786108
|
7.8% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 7.8% | ||||
| Point72 Capital Advisors, Inc. | 7.8% | ||||
| Steven A. Cohen | 7.8% | ||||
|
Anaptysbio, Inc
13G/A
Amendment 1
ANAB · 032724106
|
7.7% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 7.7% | ||||
| Point72 Capital Advisors, Inc. | 7.7% | ||||
| Steven A. Cohen | 7.7% | ||||
|
PepGen Inc.
13G/A
Amendment 1
PEPG · 713317105
|
8.2% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 8.2% | ||||
| Point72 Capital Advisors, Inc. | 8.2% | ||||
| Steven A. Cohen | 8.2% | ||||
|
Mobileye Global Inc.
13G/A
Amendment 1
MBLY · 60741F104
|
6.2% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 6.1% | ||||
| Point72 Capital Advisors, Inc. | 6.1% | ||||
| Point72 Italy S.R.L. | 0.1% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Sphere Entertainment Co.
13G/A
Amendment 3
SPHR · 55826T102
|
5.3% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.3% | ||||
| Point72 Capital Advisors, Inc. | 5.3% | ||||
| Steven A. Cohen | 5.3% | ||||
|
Sagimet Biosciences Inc.
13G/A
Amendment 2
SGMT · 786700104
|
5.7% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Tower Semiconductor Ltd
13G/A
Amendment 1
TSEM · M87915274
|
6.9% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 6.9% | ||||
| Point72 Capital Advisors, Inc. | 6.9% | ||||
| Steven A. Cohen | 6.9% | ||||
|
Alto Neuroscience, Inc.
13G/A
Amendment 2
ANRO · 02157Q109
|
7.0% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 4.6% | ||||
| Point72 Capital Advisors, Inc. | 4.6% | ||||
| Point72 Biotech Private Investments, LLC | 2.5% | ||||
| Differentiated Ventures Investments, LLC | 2.5% | ||||
| 72 Investment Holdings, LLC | 2.5% | ||||
| Steven A. Cohen | 7.0% | ||||
|
Teladoc Health, Inc.
13G/A
Amendment 2
TDOC · 87918A105
|
4.3% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 4.3% | ||||
| Point72 Capital Advisors, Inc. | 4.3% | ||||
| Steven A. Cohen | 4.3% | ||||
|
Array Technologies, Inc.
13G/A
Amendment 1
ARRY · 04271T100
|
2.0% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 2.0% | ||||
| Point72 Capital Advisors, Inc. | 2.0% | ||||
| Steven A. Cohen | 2.0% | ||||
|
aTYR PHARMA INC
13G/A
Amendment 1
ATYR · 002120202
|
3.2% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 3.2% | ||||
| Point72 Capital Advisors, Inc. | 3.2% | ||||
| Steven A. Cohen | 3.2% | ||||
|
Dyne Therapeutics, Inc.
13G/A
Amendment 1
DYN · 26818M108
|
1.5% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 1.5% | ||||
| Point72 Capital Advisors, Inc. | 1.5% | ||||
| Steven A. Cohen | 1.5% | ||||
|
Whitehawk Therapeutics, Inc.
13G/A
Amendment 1
WHWK · 00032Q104
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||